Login
$ZLAB
$23.47 -$1.13 (4.59%) Live

$ZLAB SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 Form 4: Gaynor Richard, Director

Bought 1,228 shares ($33.4K)

09 Nov 2026 D
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

–Zoci 1.6 mg/kg plus atezolizumab showed compelling 1L SCLC data at ESMO: 81.8% confirmed ORR, an estimated 81.9% six-month PFS rate and 9.1% Grade ≥3 zoci-related AEs; advancing toward a global Phase 3 study in 1L SCLC

23 Oct 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more

SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of October 22, 2026, by and among Zai Lab Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islan...

05 Oct 2026 Form 4: Chen Yajing, Chief Financial Officer

Received 920 shares by exercise or conversion · Gave up 315 shares to cover exercise price or tax ($8.03K)

21 Aug 2026 Form 4: Chen Yajing, Chief Financial Officer

Sold 260 shares ($7.02K)

20 Aug 2026 144
19 Aug 2026 144
18 Aug 2026 Form 4: Chen Yajing, Chief Financial Officer

Received 1,250 shares by exercise or conversion · Gave up 427 shares to cover exercise price or tax ($11.1K)

13 Aug 2026 Form 4: Lis William, Director

Sold 8,506 shares ($213K)

13 Aug 2026 Form 4: Chen Yajing, Chief Financial Officer

Sold 619 shares ($15.5K)

12 Aug 2026 144
11 Aug 2026 144
06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

–The Company advanced multiple global oncology and immunology programs toward key clinical and regulatory milestones, with significant pipeline catalysts expected in the second half of 2026

06 Jul 2026 Form 4: Gaynor Richard, Director

Bought 1,736 shares ($33.1K)

06 Jul 2026 Form 4: Du Ying, Director

Received 18,000 shares by exercise or conversion · Gave up 7,083 shares to cover exercise price or tax ($136K) · Received 11,048 shares by exercise or conversion · 2 more

01 Jul 2026 Form 4: Du Ying, Director

Received 17,970 shares by exercise or conversion · Sold 7,026 shares ($130K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support